|
Alomone Labs
blocking peptide Blocking Peptide, supplied by Alomone Labs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Human+Blocking+Peptides/Human+Cannabinoid+Receptor+2+(extracellular)+Blocking+Peptide/pm40359210-63-32-37 Average 93 stars, based on 1 article reviews
blocking peptide - by Bioz Stars,
2026-11
93/100 stars
|
Buy from Supplier |
|
Rockland Immunochemicals
hiv 1 tat ![]() Hiv 1 Tat, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Human+Blocking+Peptides/HIV-1+tat%2C+48-60+Peptide/pmc05861635-39-20-26 Average 88 stars, based on 1 article reviews
hiv 1 tat - by Bioz Stars,
2026-11
88/100 stars
|
Buy from Supplier |
|
Rockland Immunochemicals
α mdc1 ![]() α Mdc1, supplied by Rockland Immunochemicals, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Human+Blocking+Peptides/Human+MDC1+Peptide/pmc02854499-151-16-14 Average 85 stars, based on 1 article reviews
α mdc1 - by Bioz Stars,
2026-11
85/100 stars
|
Buy from Supplier |
|
GenScript corporation
blocking peptides corresponding to human giantin(1–469) ![]() Blocking Peptides Corresponding To Human Giantin(1–469), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Human+Blocking+Peptides/blocking+peptides+corresponding+to+human+giantin+1+469+/10__1074_slash_jbc__ra120__015661-212-7-19 Average 90 stars, based on 1 article reviews
blocking peptides corresponding to human giantin(1–469) - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Alpha Diagnostics
human rfc control/blocking peptide ![]() Human Rfc Control/Blocking Peptide, supplied by Alpha Diagnostics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Human+Blocking+Peptides/human+rfc+control+blocking+peptide/pm40289289-62-0-4 Average 90 stars, based on 1 article reviews
human rfc control/blocking peptide - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Janssen
ngf blocking protein trka peptide fused to human fc ![]() Ngf Blocking Protein Trka Peptide Fused To Human Fc, supplied by Janssen, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Human+Blocking+Peptides/ngf+blocking+protein+trka+peptide+fused+to+human+fc/pmc04012038-71-7-12 Average 90 stars, based on 1 article reviews
ngf blocking protein trka peptide fused to human fc - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
United Biosystems Inc
human atp13a2 c-terminal blocking peptide ![]() Human Atp13a2 C Terminal Blocking Peptide, supplied by United Biosystems Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Human+Blocking+Peptides/human+atp13a2+c+terminal+blocking+peptide/pmc04046687__40478_2013_6_MOESM1_ESM-14-7-12 Average 90 stars, based on 1 article reviews
human atp13a2 c-terminal blocking peptide - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
American Peptide Company Inc
blocking peptide peptide sequence: 115–122 of human α-synuclein ![]() Blocking Peptide Peptide Sequence: 115–122 Of Human α Synuclein, supplied by American Peptide Company Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/Human+Blocking+Peptides/blocking+peptide+peptide+sequence++115+122+of+human+%CE%B1+synuclein/pm17055279-92-16-26 Average 90 stars, based on 1 article reviews
blocking peptide peptide sequence: 115–122 of human α-synuclein - by Bioz Stars,
2026-11
90/100 stars
|
Buy from Supplier |
|
Human NaV1.7 (SCN9A) (extracellular) Blocking Peptide (#BLP-SC029) is the original antigen used for immunization during Anti-Human NaV1.7 (SCN9A) (extracellular) Antibody (#ASC-029) generation. The blocking peptide binds and 'blocks' Anti-Human NaV1.7 (SCN9A) (extracellular) primary antibody, this
|
Buy from Supplier |
|
Human CXCR2 (extracellular) Blocking Peptide (#BLP-CR012) is the original antigen used for immunization during Anti-Human CXCR2 (extracellular) Antibody (#ACR-012) generation. The blocking peptide binds and 'blocks' Anti-Human CXCR2 (extracellular) primary antibody, this makes it a
|
Buy from Supplier |
Image Search Results
Journal: Journal of Neuroinflammation
Article Title: Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation
doi: 10.1186/s12974-018-1129-1
Figure Lengend Snippet: Involvement of LRP1 in Tat-mediated HIV-1 LTR transactivation. a The LRP1 antagonist, receptor-associated protein (RAP), concentration dependently reduced Tat-mediated HIV-1 LTR transactivation ( n = 3; * p < 0.05). b Protein expression levels of LRP1 were significantly ( n = 3, p < 0.05) reduced in U87MG cells transfected with LRP1 siRNA (100 nM) compared to cells transfected with control (scrambled) siRNA. c siRNA knockdown of LRP1 reduced significantly ( n = 3; * p < 0.05) Tat-mediated HIV-1 LTR transactivation
Article Snippet: Cells plated on glass-bottom 35-mm 2 tissue culture dishes were co-incubated with ApoE2, ApoE3, or ApoE4 (5,10 μg/ml) and FITC-labeled
Techniques: Concentration Assay, Expressing, Transfection
Journal: Journal of Neuroinflammation
Article Title: Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation
doi: 10.1186/s12974-018-1129-1
Figure Lengend Snippet: ApoE-HDL isoform dependently affected Tat-mediated HIV-1 LTR transactivation. U87MG cells stably transfected with a luciferase gene under the control of HIV-1 Tat responsive LTR promoter were incubated for 48 h with ApoE2-HDL ( a ), ApoE3-HDL ( b ), or ApoE4-HDL ( c ) in the presence of HIV-1 Tat protein (2 μg/ml) and 100 μM chloroquine (CQ). ApoE2-HDL, ApoE3-HDL, and ApoE4-HDL significantly and concentration dependently restricted Tat-mediated HIV-1 LTR transactivation ( n = 3; * p < 0.05, ** p < 0.01, *** p < 0.001) ( d ). In comparison to ApoE2-HDL and ApoE3-HDL, ApoE4-HDL was less potent and effective at restricting Tat-mediated HIV-1 transactivation
Article Snippet: Cells plated on glass-bottom 35-mm 2 tissue culture dishes were co-incubated with ApoE2, ApoE3, or ApoE4 (5,10 μg/ml) and FITC-labeled
Techniques: Stable Transfection, Transfection, Luciferase, Incubation, Concentration Assay
Journal: Journal of Neuroinflammation
Article Title: Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation
doi: 10.1186/s12974-018-1129-1
Figure Lengend Snippet: HDL affects the ability of ApoE to restrict Tat-mediated HIV-1 LTR transactivation. a ApoE2 significantly and concentration dependently restricted Tat-mediated HIV-1 LTR transactivation in the absence of HDL ( n = 3; * p < 0.05; ** p < 0.01). b ApoE3 significantly and concentration dependently restricted Tat-mediated HIV-1 LTR transactivation in the absence of HDL ( n = 3; ** p < 0.01). c ApoE4 concentration dependently enhanced Tat-mediated HIV-1 LTR transactivation in the absence of HDL ( n = 3, ** p < 0.01). d In the presence of HDL, ApoE2 was more potent and effective at restricting Tat-mediated HIV-1 LTR transactivation. e In the presence of HDL, ApoE3 was more potent and effective at restricting Tat-mediated HIV-1 LTR transactivation. f In presence of HDL, ApoE4 concentration dependently restricted Tat-mediated HIV-1 LTR transactivation; however, in the absence of HDL, ApoE4 concentration dependently enhanced Tat-mediated HIV-1 LTR transactivation
Article Snippet: Cells plated on glass-bottom 35-mm 2 tissue culture dishes were co-incubated with ApoE2, ApoE3, or ApoE4 (5,10 μg/ml) and FITC-labeled
Techniques: Concentration Assay
Journal: Journal of Neuroinflammation
Article Title: Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation
doi: 10.1186/s12974-018-1129-1
Figure Lengend Snippet: ApoE2 and ApoE3, but not ApoE4, inhibited HIV-1 Tat internalization. Representative images ( a ) and quantified internalized fluorescence intensities ( b ) show that ApoE2 and ApoE3 at 5 and 10 μg/ml inhibited HIV-1 Tat internalization as evidenced by lower levels of punctate staining of internalized FITC-labeled Tat ( n = 30; *** p < 0.001, **** p < 0.0001), whereas ApoE4 did not inhibit HIV-1 Tat internalization
Article Snippet: Cells plated on glass-bottom 35-mm 2 tissue culture dishes were co-incubated with ApoE2, ApoE3, or ApoE4 (5,10 μg/ml) and FITC-labeled
Techniques: Fluorescence, Staining, Labeling
Journal: Journal of Neuroinflammation
Article Title: Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation
doi: 10.1186/s12974-018-1129-1
Figure Lengend Snippet: ApoE mimetic peptide decreased Tat-mediated HIV-1 LTR transactivation. a U87MG cells were treated with an ApoE mimetic peptide in the presence of HIV-1 Tat and chloroquine (CQ) for 48 h. ApoE mimetic peptide significantly reduced Tat-mediated HIV-1 LTR transactivation ( n = 3; * p < 0.05). b Incubation with an ApoE4 structure corrector, that makes the structure and function of ApoE4 more like ApoE3, enhanced the ability of ApoE4 to restrict Tat-mediated LTR transactivation ( n = 3; * p < 0.05)
Article Snippet: Cells plated on glass-bottom 35-mm 2 tissue culture dishes were co-incubated with ApoE2, ApoE3, or ApoE4 (5,10 μg/ml) and FITC-labeled
Techniques: Incubation